Another example is in hepatocellular carcinoma, where the activation of TLR4 and TLR9 by NETs led to upregulation of COX2, a potent inflammatory mediator, which enhanced the invasiveness of HCC cells (Yang et al. 2020b). This evidence concerns the gene TLR4 and hepatocellular carcinoma.